Skip to main content
PMC home page
Insights into Imaging logoLink to Insights into Imaging
. 2023 Jun 19;14:109. doi: 10.1186/s13244-023-01455-0

Bizarre parosteal osteochondromatous proliferation: an educational review

Salvatore Gitto 1,2, Francesca Serpi 2, Carmelo Messina 1,2, Domenico Albano 1, Andrea Di Bernardo 3, Elisabetta Armiraglio 3, Luca Cannavò 1, Simone Mazzoli 1, Alessandro Luzzati 1, Antonina Parafioriti 3, Luca Maria Sconfienza 1,2,✉
PMCID: PMC10279628  PMID: 37336832

Abstract

Bizarre parosteal osteochondromatous proliferation (BPOP) is a surface-based bone lesion belonging to the group of benign chondrogenic tumors. The aim of this review is to familiarize the readers with imaging features and differential diagnosis of BPOP, also addressing pathological presentation and treatment options. The peak of incidence of BPOP is in the third and fourth decades of life, although it can occur at any age. Hands are the most common location of BPOP (55%), followed by feet (15%) and long bones (25%). On imaging, BPOP appears as a well-marginated mass of heterotopic mineralization arising from the periosteal aspect of the bone. Typical features of BPOP are contiguity with the underlying bone and lack of cortico-medullary continuity, although cortical interruption and medullary involvement have been rarely reported. Histologically, BPOP is a benign bone surface lesion characterized by osteocartilaginous proliferation with disorganized admixture of cartilage with bizarre features, bone and spindle cells. Differential diagnosis includes both benign—such as florid reactive periostitis, osteochondroma, subungual exostosis, periosteal chondroma and myositis ossificans—and malignant lesions—such as periosteal chondrosarcoma and surface-based osteosarcoma. Treatment consists of surgical resection. Local recurrences are common and treated with re-excision.

Critical relevance statement Bizarre parosteal osteochondromatous proliferation is a benign mineralized mass arising from the periosteal aspect of bone cortex. Multi-modality imaging characteristics, pathology features and differential diagnosis are here highlighted to familiarize the readers with this entity and offer optimal patient care.

Keywords: Bizarre parosteal osteochondromatous proliferation, Cartilaginous tumor, Periostitis, Nora lesion, Osteochondroma

Key points

  • Bizarre parosteal osteochondromatous proliferation (BPOP) is a benign surface-based bone lesion.

  • Hands are the most common location, followed by long bones and feet.

  • BPOP is a mineralized mass arising from the periosteal aspect of bones.

  • Histologically, it is composed of a mixture of cartilage, bone, fibrous tissue.

  • Treatment consists of surgical resection, but local recurrences are common.

Background

Bizarre parosteal osteochondromatous proliferation (BPOP) was first described by Nora in 1983 and was previously known as “Nora’s lesion” [1]. The term “Nora’s lesion” is not recommended according to the 2020 World Health Organization classification of bone tumors, where BPOP is grouped within the benign chondrogenic tumors [2]. BPOP is described as a rare benign surface-based bone lesion [1]. However, its true incidence is difficult to assess, as most lesions are described in case reports or series and a few larger studies which suffer from retrospective design. Hence, BPOP may be a potentially unknown entity among many radiologists, particularly in institutions without a dedicated focus on bone tumors. The aim of this review is to familiarize the readers with imaging features and differential diagnosis of BPOP, also addressing pathological presentation and treatment options, thus increasing awareness of this entity.

Epidemiology and clinical presentation

The peak of incidence of BPOP is in the third and fourth decades of life, although it can occur at any age [3]. There is no gender predilection [3]. Etiology is currently unknown. A possible traumatic etiology has been suggested [4]. Particularly, BPOP has been viewed by some authors as the intermediate stage of a spectrum of reactive lesions, which also encompasses florid reactive periostitis (early stage) and acquired osteochondroma or turret exostosis (late stage) [4]. More recently, other authors have proposed that BPOP may represent a neoplastic rather than reactive lesion [5]. This notion is supported by the identification of recurrent cytogenetic abnormalities associated with BPOP [6].

BPOP presents clinically as a slow-growing firm mass, which is usually painless and may cause local symptoms due to mass effect [3]. Most lesions measure 1–3 cm [2]. Hands are the most common location of BPOP, accounting for 55% of cases in the largest case series to date [3], with a tendency to occur in the phalanges [7]. Particularly, in the hands, BPOP was found in the phalanges and metacarpals in 92% and 8% of cases, respectively, and favored metaphyseal and diaphyseal locations [7]. BPOP also occurs in feet and long bones in 15% and 25% of cases, respectively, most commonly at the metaphysis [3]. Other locations, such as the skull [3] and facial bones [8], are rare.

Imaging features

According to the largest radiology-based study to date, BPOP can be defined as a “well-marginated mass of heterotopic mineralization arising from the periosteal aspect of an intact cortex, without medullary changes” [7]. Some atypical imaging features representing exceptions to this general definition have been described and are detailed below. Imaging appearance also varies according to maturation of BPOP [7].

On radiographs, a periosteal soft-tissue swelling can be noted in the early stages, possibly with tiny calcifications. This mass shows progressive mineralization and becomes partially or completely ossified over several months. In the late stages, BPOP presents as sessile or pedunculated heterotopic bone formation, which is contiguous to the underlying bone cortex (Figs. 1, 2, 3, and 4) [7].

Fig. 1.

Fig. 1

Open in a new tab

BPOP arising from the proximal phalanx of the little finger. On X-rays, frontal (a) and lateral, (b) views show a well-defined mass of heterotopic mineralization, which is contiguous to the proximal phalanx. On sagittal CT image (c), the mass is cortex-based with no cortico-medullary continuity, cortical breakthrough, or marrow extension. On MRI, the mass is hypointense on T1-weighted (d) and hyperintense on T2-weighted (e) sagittal sequences, respectively. Location and imaging findings are in keeping with BPOP. Surgical resection was performed and BPOP was pathologically proven. Arrows point at BPOP in all images

Fig. 2.

Fig. 2

Open in a new tab

Recurred BPOP arising from the proximal phalanx of the little finger (same patient shown in Fig. 1). Eighteen months after surgery, BPOP recurrence is noted and shows more irregular mineralization compared to the original lesion, as shown on frontal (a) and oblique (b) X-rays views, as well on sagittal (c) and axial (d) CT images. Arrow points at BPOP in all images

Fig. 3.

Fig. 3

Open in a new tab

BPOP arising from the distal ulnar metaphysis. On X-rays, frontal (a) and lateral (b) views show a well-defined mass of heterotopic mineralization, which is contiguous to the palmar aspect of the distal ulnar metaphysis. On axial (c) and sagittal (d) CT images, the mass is cortex-based with no cortico-medullary continuity, cortical breakthrough, or marrow extension. On axial T1-weighted (e) and T2-weighted (f) MRI sequences, the mass shows low-to-intermediate and high signal, respectively. After contrast administration, marked contrast enhancement is seen on sagittal fat-saturated T1-weighted sequence (g). After biopsy, surgical resection was performed and BPOP was pathologically proven. Arrow points at BPOP in all images

Fig. 4.

Fig. 4

Open in a new tab

BPOP arising from the distal ulnar diaphysis. On X-rays, frontal (a) and lateral (b) views show a mineralized mass, which is contiguous to the distal diaphysis of the ulna. On axial T2-weighted MRI sequence (c), the mass is hyperintense with higher signal at the periphery representing cartilage covering (dashed arrow). Longitudinal B-mode ultrasound image (d) depicts a calcified mass, which is contiguous to the palmar aspect of the ulna and impinges on the flexor muscles. Axial B-mode ultrasound image (e) shows a thin hypoechoic layer (calipers) superficial to the mineralized mass, which is in keeping with cartilage covering. No increased vascularity is seen on power Doppler imaging (f). After biopsy, surgical resection was performed and BPOP was pathologically proven. White arrow points at BPOP in all images

CT shows the same features of BPOP as described on radiographs, with better anatomical detail. Particularly, in the late stages, an ossified surface-based mass is depicted in contiguity but no continuity with the underlying cortex (Figs. 1, 2, 3 and 5). No evidence of cortical breakthrough or bone marrow extension is typically seen [7, 9]. However, atypical findings of cortical destruction [10] and cortico-medullary continuity with the underlying bone [11, 12] have been reported.

Fig. 5.

Fig. 5

Open in a new tab

Recurred BPOP arising from the distal ulnar diaphysis (same patient shown in Fig. 4). Three years after surgery, BPOP recurrence presents as a cortex-based completely ossified mass, which is contiguous to the palmar-radial aspect of the ulna. On MRI, the ossified component of the mass is hyperintense on both T2-weighted (a, b) and T1-weighted (c) sequences. After contrast administration, contrast enhancement is noted on fat-saturated T1-weighted sequence (d). No cortical breakthrough is seen on CT (e). White arrow points at BPOP in all images. Dashed arrow points at the outermost cartilaginous layer of BPOP in (b)

On MRI, BPOP shows low-to-intermediate signal on T1-weighted sequences and intermediate-to-high signal with hyperintensity at the periphery representing cartilage on T2-weighted sequences, respectively. After intravenous contrast administration, contrast enhancement is seen [13]. Normal cortical appearance and absent marrow signal changes are typical features of BPOP and well depicted on MRI (Figs. 1, 3, 4, and 5) [13]. However, atypical findings of cortico-medullary continuity with the underlying bone [11, 12], cortical invasion [14, 15] and reactive signal changes in the adjacent bone marrow and soft-tissues [16] have been reported.

On ultrasound, BPOP presents as a calcified soft-tissue mass, which has no continuity with the underlying bone cortex (Fig. 4) [7].

Differential diagnosis

Accurate imaging evaluation is crucial for guiding patient care, as imaging features of BPOP may mimic other benign and aggressive surface-based bone lesions. Patient age, lesion location and main imaging characteristics useful for differentiating these entities from BPOP are discussed below.

Florid reactive periostitis (also known as fibro-osseous pseudotumor of digits) It has been viewed by some authors as the early stage of a spectrum of reactive lesions, which could mature into BPOP [4]. However, according to the 2020 World Health Organization classification of bone tumors, BPOP is considered as a separate entity and possible neoplastic etiology is suggested [2]. Like BPOP, florid reactive periostitis occurs most commonly in the phalanges of the hands and feet and, less frequently, in metacarpals, metatarsals and long bones [5]. It is mostly seen in young adults ranging in age from 20 to 40 years [5], similar as BPOP. On imaging, a soft-tissue swelling with heterotopic ossification is seen in contiguity with an intact bone cortex [17, 18], although cortical destruction has been occasionally reported [18]. Periosteal reaction is usually present [17]. Over weeks to months, periosteal reaction maturation can occur and result in a soft-tissue calcified shadow, which is also known as florid reactive periostitis ossificans (Fig. 6) [5].

Fig. 6.

Fig. 6

Open in a new tab

Florid reactive periostitis. On lateral X-rays view (a), a soft-tissue swelling is noted in contiguity with the volar aspect of the distal humerus. On axial (b) and sagittal (c) CT images, a partially mineralized mass with peripheral calcifications and mild periosteal thickening is noted. No cortical discontinuity is seen. Three months later, peripheral calcifications become more prominent, as shown in axial (d) and sagittal (e) CT images. Florid reactive periostitis ossificans was pathologically proven. Arrow points at the lesion in all images

Osteochondroma It is a cartilage-capped osseous exophytic lesion arising from metaphysis or metaphyseal equivalents, which can be either sessile (broad base exceeding its length) or pedunculated (narrow base exceeded by its length) [19]. It is usually discovered in the first three decades of life. Osteochondroma is mostly located in long bones, particularly femur and tibia. Solitary osteochondroma rarely occurs in the hands and feet [19]. Unlike BPOP (with typical features), osteochondroma exhibits cortico-medullary continuity with the underlying native bone (Fig. 7). Additionally, it has an uniform cartilaginous cap, which may show calcifications and differs from the disorganized cartilage covering observed in the outermost layer of BPOP [19]. Cortico-medullary continuity and cartilaginous cap are best evaluated on CT and MRI, which may also depict enlargement of the cartilaginous cap (> 1.5 cm after skeletal maturity) suggesting degeneration to secondary peripheral chondrosarcoma [20]. Finally, osteochondroma is usually oriented away from the nearest joint and extends parallel to the long axis of the native bone [19].

Fig. 7.

Fig. 7

Open in a new tab

Osteochondroma. On axial CT (a) and T1-weighted MRI (b) images, osteochondroma (white arrow) exhibits cortico-medullary continuity with the underlying native bone. On axial fat-saturated T2-weighted MRI sequence, the lesion shows a thin and uniform cartilaginous cap (dashed arrow). Osteochondroma was pathologically proven

Subungual exostosis It is an osteocartilaginous proliferation arising from the distal phalanx of the fingers or toes [5]. It commonly presents in adolescents and young adults [5], similar as BPOP. On imaging, subungual exostosis appears as a bony outgrowth that projects from the dorsal aspect of the terminal phalanx. Unlike osteochondroma, subungual exostosis reveals no cortical or marrow continuity with the underlying bone (Fig. 8) [21].

Fig. 8.

Fig. 8

Open in a new tab

Subungual exostosis. On X-rays (a), a mineralized mass is noted in contiguity with the dorsal aspect of the distal phalanx of the big toe. On sagittal CT (b) and T1-weighted MRI (c) images, no cortical or marrow continuity with the underlying bone is seen. Subungual exostosis was pathologically proven. Arrow points at the lesion in all images

Periosteal chondroma and periosteal chondrosarcoma Periosteal chondroma and chondrosarcoma are cartilage-forming tumors arising from metaphysis and diaphysis of tubular bones [22]. They are mostly located in the humerus and femur [22]. Less frequently, periosteal chondroma is found in the hands [23]. Periosteal chondroma and chondrosarcoma often occur in young adults, similar as BPOP [22, 23]. Size is the most useful imaging feature to differentiate between periosteal chondroma and chondrosarcoma, which are usually smaller and larger than 3 cm, respectively [19, 24]. They are both lobular iuxta-cortical masses showing “rings and arcs” calcifications on radiographs and CT, as well as high signal on T2-weighted sequence, low signal on T1-weigthed sequence and peripheral and septal contrast enhancement on MRI, which are in keeping with chondroid matrix [19, 24]. However, these findings are subtle compared to centrally located lesions. Unlike BPOP, periosteal chondroma and periosteal chondrosarcoma exhibit saucerization and sclerotic margination of the underlying cortex, as well as dense periosteal reaction. Metaplastic ossification, aggressive periosteal reaction like Codman triangle, cortical invasion, intramedullary extension and tendency to permeate into the adjacent soft tissues are suggestive of periosteal chondrosarcoma rather than chondroma (Fig. 9) [19, 24]. However, imaging features of periosteal chondroma and chondrosarcoma often overlap, and tissue sampling is then required for definitive diagnosis.

Fig. 9.

Fig. 9

Open in a new tab

Periosteal chondrosarcoma. On X-rays (a, b), a mineralized surface-based mass of the proximal humerus is seen. On axial CT image (c), the mass is cortex-based and partially ossified. Cortical remodeling and erosion (dashed arrow) are noted. On axial T1-weighted (d) and proton density-weighted (e) MRI sequences, the mass shows low and high signal, respectively. No marrow or soft-tissue extension is noted. Periosteal chondrosarcoma was pathologically proven. White arrow points at the lesion in all images

Surface-based osteosarcoma Surface osteosarcoma includes parosteal, periosteal and high-grade surface osteosarcoma [2]. Periosteal and high-grade surface osteosarcomas are of intermediate and high-grade, respectively, and show aggressive features such as aggressive periosteal reaction (periosteal variant), large circumferential cortical involvement (≥ 50%), cortical erosion and medullary involvement (high-grade surface variant) [24], which help in differentiating them from BPOP. Conversely, parosteal osteosarcoma is of low-grade [24] and may mimic BPOP. It most commonly affects patients in the second-to-fourth decades, similar as BPOP [24]. It has predilection for long bones and is typically metaphyseal in location or, occasionally, diaphyseal or meta-diaphyseal [24]. Unlike BPOP, parosteal osteosarcoma rarely occurs in the hands [25] and feet [26]. Parosteal osteosarcoma presents as a heavily ossified lobular exophytic mass with soft-tissue component, which is denser centrally than at the periphery (Fig. 10). An incomplete and irregular cartilaginous covering may infrequently be present. Unlike BPOP (with typical features), it can be associated with cortical erosion and medullary involvement. Periosteal reaction is uncommon unless dedifferentiation occurs [24].

Fig. 10.

Fig. 10

Open in a new tab

Parosteal osteosarcoma. On X-rays (a), an exophytic heavily ossified mass is seen in contiguity with the medial aspect of the femoral neck. On coronal (b) and axial (c) CT images, the mass is denser centrally than at the periphery. The mass shows predominantly low signal representing mineralized component on both coronal T1-weighted (d) and axial T2-weighted (e) MRI sequences. Parosteal osteosarcoma was pathologically proven. Arrow points at the lesion in all images

Myositis ossificans It is a tumor mimicker resulting from heterotopic bone formation, typically following trauma [27]. It can occur at any age. Unlike BPOP, ossification progresses from periphery to center. Thus, the major distinguishing feature of myositis ossificans is the “zonal phenomenon,” which represents peripheral mineralization with central lucency (Fig. 11). Additionally, myositis ossificans is usually separated from the adjacent bone but, as the lesion matures, a stalk of attachment to the underlying bone can be seen [27].

Fig. 11.

Fig. 11

Open in a new tab

Myositis ossificans. On coronal fat-saturated T2-weighted MRI sequence (a), an intermediate-to-high signal mass is noted close to the medial aspect of the proximal humerus. This mass is separated from the underlying bone. A central chondroid lesion of the humerus is also seen. On CT (b), “zonal phenomenon” with peripheral mineralization and central lucency is shown. Myositis ossificans was pathologically proven. Arrow points at myositis ossificans in both images

Pathology

Macroscopically, BPOP is a bony surface-based lesion with cartilaginous covering. Histologically, it is composed of a variable mixture of cartilage, bone, and fibrous tissue (Fig. 12a) [28]. The outermost part consists of hyaline cartilage and fibrocartilaginous tissue. The intermediate layer consists of cartilage-to-bone transition via enchondral ossification. The innermost part consists of trabecular bone and intertrabecular spaces containing hypervascular tissue and spindle cells. A distinguishing feature of BPOP is basophilic stroma between cartilage and bone, known as “blue bone” (Fig. 12b). The cartilage component is hypercellular and chondrocytes show atypical features, such as enlarged nuclei and binucleation (bizarre nuclei) and myxoid features (Fig. 12c, d) [2]. Differential diagnosis includes both benign—such as osteochondroma and reactive periostitis—and malignant bone surface lesions—such as chondrosarcoma and surface osteosarcoma with prominent chondroblastic component [29–32].

Fig. 12.

Fig. 12

Open in a new tab

Pathological features of BPOP. Low power view of disorganized bone and cartilaginous cap (a). Characteristic basophilic stroma called “blue bone” (b). Myxoid areas with smaller spindle shaped chondrocytes (c). Atypical chondrocytes with hyperchromatic and enlarged nuclei (d)

Treatment and outcome

BPOP is a benign, slow-growing lesion which can be managed conservatively unless symptomatic. Treatment consists of surgical resection, which is aimed at alleviating symptoms and achieving definitive pathological diagnosis in doubtful cases. Wide resection has been proposed to reduce recurrency rates [33]. Wide resection consists of en bloc excision including the lesion with the pseudocapsule and any periosteal tissue beneath it, followed by decortication of any abnormal-appearing areas in the underlying bone [33]. However, a relatively tissue-conserving approach can be adopted in selected cases given the potential surgical morbidity associated with wide resection [34].

BPOP recurrence is relatively frequent and has been reported in up to 55% of cases, sometimes multiple times [3]. Recurrences present as partially or completely ossified masses with more irregular mineralization compared to the original lesions (Figs. 2 and 5) [7]. Recurrences are managed by re-excision [34]. BPOP has no capacity to metastasize [2].

Conclusions

BPOP must be included in the differential diagnosis of mineralized masses arising from the periosteal aspect of bone cortex. If location and imaging features are strongly suggestive of BPOP, such as mineralized lesions arising from the phalanges with no cortical erosion or medullary involvement, a watchful waiting strategy with follow-up imaging examinations can be adopted [7]. If clinical and imaging presentation is unclear, biopsy should be performed as the next step [35, 36]. Familiarity with multi-modality imaging characteristics, pathology features and differential diagnosis is desirable to offer optimal patient care.

Abbreviation

BPOP

Bizarre parosteal osteochondromatous proliferation

Author contributions

Conception (SG); data acquisition and analysis (SG, FS, CM, DA, ADB, EA, LC, SM); manuscript draft (SG); manuscript revision (AL, AP, LMS). All authors approved the final manuscript.

Funding

Investigator Grant awarded by Fondazione AIRC per la Ricerca sul Cancro for the project “RADIOmics-based machine-learning classification of BOne and Soft Tissue Tumors (RADIO-BOSTT)” (LMS). This research was supported by the Italian Ministry of Health (MOH), which also supported the APC fee. The funding source provided financial support without any influence on the study design, on the acquisition and analysis of data, and on the writing of the manuscript.

Availability of data and materials

Not applicable.

Declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

LM Sconfienza is member of the Insights into Imaging Advisory Editorial Board. He has not taken part in the review or selection process of this article. The remaining authors declare that they have no competing interests.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Nora FE, Dahlin DC, Beabout JW. Bizarre parosteal osteochondromatous proliferations of the hands and feet. Am J Surg Pathol. 1983;7:245–250. doi: 10.1097/00000478-198304000-00003. [DOI] [PubMed] [Google Scholar]
  • 2.WHO Classification of Tumours Editorial Board . WHO classification of tumours: soft tissue and bone tumours. Lyon: International Agency for Research on Cancer Press; 2020. [Google Scholar]
  • 3.Meneses MF, Unni KK, Swee RG. bizarre parosteal osteochondromatous proliferation of bone (Noraʼs lesion) Am J Surg Pathol. 1993;17:691–697. doi: 10.1097/00000478-199307000-00006. [DOI] [PubMed] [Google Scholar]
  • 4.Yuen M, Friedman L, Orr W, Cockshott WP. Proliferative periosteal processes of phalanges: a unitary hypothesis. Skeletal Radiol. 1992;21:1520. doi: 10.1007/BF00241768. [DOI] [PubMed] [Google Scholar]
  • 5.Memon RA, Wei S, Siegal GP. Some reactive lesions of bone are probably neoplasms. Arch Pathol Lab Med. 2022;146:60–69. doi: 10.5858/arpa.2020-0817-RA. [DOI] [PubMed] [Google Scholar]
  • 6.Joseph J, Ritchie D, MacDuff E, Mahendra A. Bizarre parosteal osteochondromatous proliferation: a locally aggressive benign tumor. Clin Orthop Relat Res. 2011;469:2019–2027. doi: 10.1007/s11999-011-1898-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Dhondt E, Oudenhoven L, Khan S, et al. Nora’s lesion, a distinct radiological entity? Skeletal Radiol. 2006;35:497–502. doi: 10.1007/s00256-005-0041-9. [DOI] [PubMed] [Google Scholar]
  • 8.Ganguly R, Jordan RC. Bizarre parosteal osteochondromatous proliferation (Nora’s lesion) of mandible with recurrence: case report and review of literature. J Oral Maxillofac Surg. 2021;79:1074–1080. doi: 10.1016/j.joms.2020.10.035. [DOI] [PubMed] [Google Scholar]
  • 9.Washington E, Menendez L, Fedenko A, Tomasian A. Bizarre parosteal osteochondromatous proliferation: rare case affecting distal ulna and review of literature. Clin Imaging. 2021;69:233–237. doi: 10.1016/j.clinimag.2020.08.019. [DOI] [PubMed] [Google Scholar]
  • 10.Abramovici L, Steiner GC. Bizarre parosteal osteochondromatous proliferation (Nora’s lesion): a retrospective study of 12 cases, 2 arising in long bones. Hum Pathol. 2002;33:1205–1210. doi: 10.1053/hupa.2002.130103. [DOI] [PubMed] [Google Scholar]
  • 11.Rybak LD, Abramovici L, Kenan S, Posner MA, Bonar F, Steiner GC. Cortico-medullary continuity in bizarre parosteal osteochondromatous proliferation mimicking osteochondroma on imaging. Skeletal Radiol. 2007;36:829–834. doi: 10.1007/s00256-007-0300-z. [DOI] [PubMed] [Google Scholar]
  • 12.Sakamoto A, Imamura S, Matsumoto Y, et al. Bizarre parosteal osteochondromatous proliferation with an inversion of chromosome 7. Skeletal Radiol. 2011;40:1487–1490. doi: 10.1007/s00256-011-1173-8. [DOI] [PubMed] [Google Scholar]
  • 13.Torreggiani WC, Munk PL, Al-Ismail K, et al. MR imaging features of bizarre parosteal osteochondromatous proliferation of bone (Nora’s lesion) Eur J Radiol. 2001;40:224–231. doi: 10.1016/S0720-048X(01)00362-X. [DOI] [PubMed] [Google Scholar]
  • 14.Helliwell TR, O’Connor MA, Ritchie DA, Feldberg L, Stilwell JH, Jane MJ. Bizarre parosteal osteochondromatous proliferation with cortical invasion. Skeletal Radiol. 2001;30:282–285. doi: 10.1007/s002560100347. [DOI] [PubMed] [Google Scholar]
  • 15.Teoh KH, Shortt N, Wilkinson G, Salter DM, Robb JE, Porter DE. Bizarre parosteal osteochondromatous proliferation of the metatarsal: a pediatric case report and archival review. J Foot Ankle Surg. 2009;48:690.e7–690.e11. doi: 10.1053/j.jfas.2009.06.012. [DOI] [PubMed] [Google Scholar]
  • 16.Orui H, Ishikawa A, Tsuchiya T, Ogino T. Magnetic resonance imaging characteristics of bizarre parosteal osteochondromatous proliferation of the hand: a case report. J Hand Surg Am. 2002;27:1104–1108. doi: 10.1053/jhsu.2002.36526. [DOI] [PubMed] [Google Scholar]
  • 17.Mathew SE, Madhuri V, Alexander M, Walter NM, Gibikote SV. Florid reactive periostitis of the forearm bones in a child. J Bone Jt Surg Br. 2011;93-B:418–420. doi: 10.1302/0301-620X.93B3.24955. [DOI] [PubMed] [Google Scholar]
  • 18.Gao Z, Wang J, Wang Z, Meng Q. Florid reactive periostitis of the metacarpal and phalanx: 2 case reports. J Hand Surg Am. 2013;38:2134–2137. doi: 10.1016/j.jhsa.2013.08.115. [DOI] [PubMed] [Google Scholar]
  • 19.Gholamrezanezhad A, Basques K, Kosmas C. Peering beneath the surface: juxtacortical tumors of bone (part I) Clin Imaging. 2018;51:1–11. doi: 10.1016/j.clinimag.2018.01.009. [DOI] [PubMed] [Google Scholar]
  • 20.Murphey MD, Choi JJ, Kransdorf MJ, Flemming DJ, Gannon FH. Imaging of osteochondroma: variants and complications with radiologic-pathologic correlation. Radiographics. 2000;20:1407–1434. doi: 10.1148/radiographics.20.5.g00se171407. [DOI] [PubMed] [Google Scholar]
  • 21.Mundada P, Becker M, Lenoir V, et al. High resolution MRI of nail tumors and tumor-like conditions. Eur J Radiol. 2019;112:93–105. doi: 10.1016/j.ejrad.2019.01.004. [DOI] [PubMed] [Google Scholar]
  • 22.Goedhart LM, Ploegmakers JJW, Kroon HM, Zwartkruis ECH, Jutte PC. The presentation, treatment and outcome of periosteal chondrosarcoma in the Netherlands. Bone Jt J. 2014;96-B:823–828. doi: 10.1302/0301-620X.96B6.33037. [DOI] [PubMed] [Google Scholar]
  • 23.Rabarin F, Laulan J, Saint Cast Y, Césari B, Fouque P-A, Raimbeau G. Focal periosteal chondroma of the hand: a review of 24 cases. Orthop Traumatol Surg Res. 2014;100:617–620. doi: 10.1016/j.otsr.2014.05.014. [DOI] [PubMed] [Google Scholar]
  • 24.Harper K, Sathiadoss P, Saifuddin A, Sheikh A. A review of imaging of surface sarcomas of bone. Skeletal Radiol. 2021;50:9–28. doi: 10.1007/s00256-020-03546-1. [DOI] [PubMed] [Google Scholar]
  • 25.Rossetti A, Fily A, Dreano T, Ropars M, Maximen J. Parosteal osteosarcoma of the thumb: a case report and literature review. Hand Surg Rehabil. 2022;41:273–277. doi: 10.1016/j.hansur.2022.01.005. [DOI] [PubMed] [Google Scholar]
  • 26.Johnson K, Davies AM, Mangham DC, Grimer RJ. Parosteal osteosarcoma of a metatarsal with intramedullary invasion. Skeletal Radiol. 1999;28:111–115. doi: 10.1007/s002560050485. [DOI] [PubMed] [Google Scholar]
  • 27.Gholamrezanezhad A, Basques K, Kosmas C. Peering beneath the surface: juxtacortical tumors of bone (part II) Clin Imaging. 2018;50:113–122. doi: 10.1016/j.clinimag.2018.01.005. [DOI] [PubMed] [Google Scholar]
  • 28.Cocks M, Helmke E, Meyers CA, Fayad L, McCarthy E, James AW. Bizarre parosteal osteochondromatous proliferation: 16 cases with a focus on histologic variability. J Orthop. 2018;15:138–142. doi: 10.1016/j.jor.2018.01.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Meazza C, Giovanna S, Nigro O, et al. Secondary osteosarcoma: a challenge indeed. Int J Clin Oncol. 2023;28:184–190. doi: 10.1007/s10147-022-02267-w. [DOI] [PubMed] [Google Scholar]
  • 30.Meazza C, Cefalo G, Massimino M, et al. Primary metastatic osteosarcoma: results of a prospective study in children given chemotherapy and interleukin-2. Med Oncol. 2017;34:191. doi: 10.1007/s12032-017-1052-9. [DOI] [PubMed] [Google Scholar]
  • 31.Meazza C, Luksch R, Daolio P, et al. Axial skeletal osteosarcoma: a 25-year monoinstitutional experience in children and adolescents. Med Oncol. 2014;31:875. doi: 10.1007/s12032-014-0875-x. [DOI] [PubMed] [Google Scholar]
  • 32.Parafioriti A, Cifola I, Gissi C, et al. Expression profiling of microRNAs and isomiRs in conventional central chondrosarcoma. Cell Death Discov. 2020;6:46. doi: 10.1038/s41420-020-0282-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Michelsen H, Abramovici L, Steiner G, Posner MA. Bizarre parosteal osteochondromatous proliferation (Nora’s lesion) in the hand. J Hand Surg Am. 2004;29:520–525. doi: 10.1016/j.jhsa.2004.02.002. [DOI] [PubMed] [Google Scholar]
  • 34.Berber O, Dawson-Bowling S, Jalgaonkar A, et al. Bizarre parosteal osteochondromatous proliferation of bone. J Bone Jt Surg Br. 2011;93:1118–1121. doi: 10.1302/0301-620X.93B8.26349. [DOI] [PubMed] [Google Scholar]
  • 35.Cannavò L, Albano D, Messina C, et al. Accuracy of CT and MRI to assess resection margins in primary malignant bone tumours having histology as the reference standard. Clin Radiol. 2019;74:736.e13–736.e21. doi: 10.1016/j.crad.2019.05.022. [DOI] [PubMed] [Google Scholar]
  • 36.Albano D, Messina C, Gitto S, Papakonstantinou O, Sconfienza L. Differential diagnosis of spine tumors: my favorite mistake. Semin Musculoskelet Radiol. 2019;23:026–035. doi: 10.1055/s-0038-1675551. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Not applicable.

Articles from Insights into Imaging are provided here courtesy of Springer

RESOURCES